drugset / Trial / NCT05508659
A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors
RandomizedParallel-groupOpen-labelTreatment
Summary
Study will be conducted with 2 stages.
Timeline
- Start
- 2022-09-20
- Primary completion
- 2024-09-20
- Completion
- 2025-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duvelisib | Small molecule | — | Oral |
| Subject | Enlonstobart | Monoclonal antibody | 240 mg | Intravenous |